Dr. Geschwind has also played a crucial role in more than 50 clinical trials aimed at testing and developing new treatments for liver cancer. These trials have paved the way for cutting-edge therapies, including intraarterial therapy using radioactive microspheres and noninvasive ultrasound-guided treatments for liver and kidney cancer. https://medicine.yale.edu/news/yale-medicine-magazine/article/jeff-geschwind-md-to-chair-diagnostic-radiology/